GW Pharmaceuticals logo

GWPH - GW Pharmaceuticals Share Price

$97.65 5.9  6.5%

Last Trade - 08/04/20

Sector
Healthcare
Size
Mid Cap
Market Cap £2.30bn
Enterprise Value £1.82bn
Revenue £15.7m
Position in Universe 1286th / 6315
Bullish
Bearish
Unlock GWPH Revenue
Momentum
Relative Strength (%)
1m
3m
6m
1yr
Volume Change (%)
10d / 3m
Price vs... (%)
52w High
50d MA
200d MA
Margin of Safety
Qualifying GuruScreens
Health Trend(F-Score)
0 1 2 3 4 5 6 7 8 9
Bankruptcy Score(Z-Score)
Distress
Cautious
Safe
Earnings Manipulation Risk(M-Score)
Other Ratios
Recent History
Latest interim period vs. prior period Industry Market
3yr Compound Annual Growth Rate Industry Market
Graphical History

Revenue

GWPH Revenue Unlock GWPH Revenue

Net Income

GWPH Net Income Unlock GWPH Revenue

Normalised EPS

GWPH Normalised EPS Unlock GWPH Revenue

PE Ratio Range

GWPH PE Ratio Range Unlock GWPH Revenue

Dividend Yield Range

GWPH Dividend Yield Range Unlock GWPH Revenue
Analyst Forecasts
Price Target:
( below Price)
31st Dec 2020
31st Dec 2021
Est. Long Term Growth Rate: Net Profit
()
EPS
()
DPS
()
Net Profit
()
EPS
()
DPS
()
Consensus Estimate
1m Change
3m Change
Analyst Consensus
Strong Sell Sell Hold Buy Strong Buy
EPS 2019 /  2020
GWPH EPS Forecasts Unlock GWPH Revenue
Profile Summary

GW Pharmaceuticals plc is a biopharmaceutical company focused on developing and commercializing therapeutics from its cannabinoid product platform in a range of disease areas. The Company's lead cannabinoid product candidate is Epidiolex, which is a liquid formulation of pure plant-derived cannabidiol (CBD). The Company offers Sativex (nabiximols), which is indicated for the treatment of spasticity due to multiple sclerosis (MS). The Company is also focused on developing its pharmaceutical product pipelines, which includes Epidiolex for the treatment of Tuberous Sclerosis Complex and RETT Syndrome.

Directors
Last Annual December 31st, 2018
Last Interim December 31st, 2018
Incorporated February 15, 2001
Public Since June 21, 2001
No. of Shareholders: n/a
No. of Employees: 901
Sector Healthcare
Industry Biotechnology & Medical Research
Index Nasdaq Composite ,
Exchange NASDAQ Global Market
Shares in Issue 30,922,370
Free Float (0.0%)
Eligible for
ISAs
SIPPs
GWPH Share Price Performance
Share Price
Bid - Ask
Low - High
Spread
Day's Change
Avg Volume
Open - Close
Range (12m)
Beta
Latest News for GWPH
Upcoming Events for GWPH
Monday 4th May, 2020 Estimate
Q1 2020 GW Pharmaceuticals PLC Earnings Release
Friday 12th June, 2020 Estimate
GW Pharmaceuticals PLC Annual Shareholders Meeting
Tuesday 4th August, 2020 Estimate
Half Year 2020 GW Pharmaceuticals PLC Earnings Release
Similar to GWPH
© Stockopedia 2020, Refinitiv, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.